Ido Marom - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 16:04:48 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ido Marom

Key filing fact

Ido Marom filed Form 3 for Brainsway Ltd. (BWAY) on 18 Mar 2026.

Key facts

  • This page summarizes Ido Marom's Form 3 filing for Brainsway Ltd. (BWAY).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 16:04.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111633 Primary reporting owner

Marom Ido

Relationship
Chief Financial Officer
Address
16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL
Signature
/s/ Ido Marom
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWAY holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
51,250
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BWAY holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
46,875
Exercise price
Footnotes
F1, F3, F4
BWAY holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
17,500
Exercise price
Footnotes
F1, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

This figure includes unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 8,750 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029, and (c) RSUs to receive 32,500 ordinary shares with 8,125 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

Footnote F3

Stock options were granted on August 8, 2023, with the remaining options to purchase 46,875 ordinary shares vesting in equal quarterly installments until May 18, 2027.

Footnote F4

The exercise price is NIS 4.28 per share.

Footnote F5

Stock options were granted on March 5, 2024, with the remaining options to purchase 17,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.

Footnote F6

The exercise price is NIS 11.17 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .